PNC Financial Services Group’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$502K Buy
3,769
+3
+0.1% +$340 ﹤0.01% 1783
2026
Q1
$419K Buy
3,766
+521
+16% +$61.7K ﹤0.01% 1804
2025
Q4
$438K Buy
3,245
+3,104
+2,201% +$339K ﹤0.01% 1754
2025
Q3
$12K Buy
+141
New +$8.64K ﹤0.01% 3862

Other funds holding ABVX

PNC Financial Services Group's ABVX Position: Q2 2026 in Review

PNC Financial Services Group increased its Abivax (ABVX) stake by 0.08% in Q2 2026, buying an estimated $340 and bringing the position to 3,769 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #1783.

PNC Financial Services Group first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 111 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • PNC Financial Services Group held 3,769 shares of Abivax worth $502K as of Q2 2026.
  • PNC Financial Services Group bought 3 Abivax shares in Q2 2026, an estimated $340.
  • Abivax made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1783 holding.
  • PNC Financial Services Group first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 111 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.